** = Publications listed in SCI/SSCI/Pubmed
** Feuerstein, A; Schoenrath, F; Belyavskiy, E; Knierim, J; Friede, T; Placzek, M; Bach, D; Pieske-Kraigher, E; Herrmann-Lingen, C; Westenfeld, R; Roden, M; Rybczynski, M; Verheyen, N; Dörr, M; von, Haehling, S; Störk, S; Halle, M; Falk, V; Pieske, B; Edelmann, F
Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial (Ex-VAD trial).
Eur J Heart Fail. 2023;
Doi: 10.1002/ejhf.3032
Web of Science
PubMed
FullText
FullText_MUG
** Koestenberger, M; Belyavskiy, E
Myocardial strain analysis in infants with pectus excavatum: A subtle method to detect myocardial impairment?
J CLIN ULTRASOUND. 2021; 49(9): 929-931.
Doi: 10.1002/jcu.23085
Web of Science
PubMed
FullText
FullText_MUG
** Belyavskiy, E; Morris, DA; Url-Michitsch, M; Verheyen, N; Meinitzer, A; Radhakrishnan, AK; Kropf, M; Frydas, A; Ovchinnikov, AG; Schmidt, A; Tadic, M; Genger, M; Lindhorst, R; Bobenko, A; Tschöpe, C; Edelmann, F; Pieske-Kraigher, E; Pieske, B
Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study.
ESC Heart Fail. 2019; 6(1):146-153
Doi: 10.1002/ehf2.12375
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Belyavskiy, E; Morris, DA; Url-Michitsch, M; Verheyen, N; Krishnan, AKR; Frydas, A; Huang, F; Kropf, M; Lindhorst, R; Bobenko, A; Tadic, M; Tschoepe, C; Edelmann, F; Pieske-Kraigher, E; Pieske, B
Potential usefulness of diastolic stress-test echocardiography in patients with suspicion of heart failure with preserved ejection fraction - a pilot study
EUR J HEART FAIL. 2018; 20: 231-232.
[Poster]
Web of Science
** Verheyen, N; Fahrleitner-Pammer, A; Belyavskiy, E; Gruebler, MR; Dimai, HP; Amrein, K; Ablasser, K; Martensen, J; Catena, C; Pieske-Kraigher, E; Colantonio, C; Voelkl, J; Lang, F; Alesutan, I; Meinitzer, A; März, W; Brussee, H; Pieske, B; Pilz, S; Tomaschitz, A
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.
PLoS One. 2017; 12(4):e0173799-e0173799
Doi: 10.1371/journal.pone.0173799
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Meinitzer, A; Grübler, MR; Ablasser, K; Kolesnik, E; Fahrleitner-Pammer, A; Belyavskiy, E; Trummer, C; Schwetz, V; Pieske-Kraigher, E; Voelkl, J; Alesutan, I; Catena, C; Sechi, LA; Brussee, H; Lewinski, DV; März, W; Pieske, B; Pilz, S; Tomaschitz, A
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
Clin Chem Lab Med. 2017; 55(7):1034-1042
Doi: 10.1515/cclm-2016-1159
Web of Science
PubMed
FullText
FullText_MUG
** Wetzel, J; Pilz, S; Grübler, MR; Fahrleitner-Pammer, A; Dimai, HP; von Lewinski, D; Kolesnik, E; Perl, S; Trummer, C; Schwetz, V; Meinitzer, A; Belyavskiy, E; Völkl, J; Catena, C; Brandenburg, V; März, W; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, ND
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.
J Clin Hypertens (Greenwich). 2017; 19(11):1173-1180
Doi: 10.1111/jch.13064
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Verheyen, N; Meinitzer, A; Pieske, B; Belyavskiy, E; Brussee, H; Haas, J; März, W; Pieske-Kraigher, E; Verheyen, S; Ofner-Ziegenfuss, L; Hartaigh, BÓ; Schwetz, V; Aberer, F; Grübler, M; Lang, F; Alesutan, I; Voelkl, J; Gaksch, M; Horina, JH; Dimai, HP; Rus-Machan, J; Stiegler, C; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
J Hypertens. 2016; 34(7):1347-56
Doi: 10.1097/HJH.0000000000000927
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Fahrleitner-Pammer, A; Pieske, B; Meinitzer, A; Belyavskiy, E; Wetzel, J; Gaksch, M; Grübler, MR; Catena, C; Sechi, LA; Van, Ballegooijen, AJ; Brandenburg, VM; Scharnagl, H; Perl, S; Brussee, H; März, W; Pilz, S; Tomaschitz, A
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
J Hypertens. 2016; 34(9):1778-86
Doi: 10.1097/HJH.0000000000001004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, ND; Kienreich, K; Gaksch, M; van, Ballegooijen, AJ; Grübler, MR; Hartaigh, BÓ; Schmid, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Colantonio, C; Belyavskiy, E; Treiber, G; Catena, C; Brussee, H; Pieske, B; März, W; Tomaschitz, A; Pilz, S
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2016; 18(6):543-50
Doi: 10.1111/jch.12710
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Belyavskiy, E; Kraigher-Krainer, E; Morris, DA; Url-Michitsch, M; Krishnan, AR; Kropf, M; Kraft, R; Meinitzer, A; Schmidt, A; Pieske, B
Diagnostic relevance of diastolic stress-test echocardiography in patients with suspicion of heart failure with preserved ejection fraction
EUR J HEART FAIL. 2016; 18: 306-306.
[Poster]
Web of Science
** Wetzel, J; Pilz, S; Gruebler, M; Fahrleitner-Pammer, A; Dimai, HP; Von Lewinski, D; Kolesnik, E; Perl, S; Weinrauch, V; Maerz, W; Belyavskiy, E; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, N
Parathyroid hormone is independently associated with systolic blood pressure, pulse wave velocity and left ventricular mass index in patients with primary hyperparathyroidism
EUR HEART J. 2016; 37: 417-417.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY.
[Poster]
Web of Science
** Tomaschitz, A; Verheyen, N; Gaksch, M; Meinitzer, A; Pieske, B; Kraigher-Krainer, E; Colantonio, C; März, W; Schmidt, A; Belyavskiy, E; Rus-Machan, J; van, Ballegooijen, AJ; Stiegler, C; Amrein, K; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Homoarginine in patients with primary hyperparathyroidism.
Am J Med Sci. 2015; 349(4):306-11
Doi: 10.1097/MAJ.0000000000000419
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Wetzel, J; Martensen, J; Belyavskiy, E; Schmidt, A; Colantonio, C; Catena, C; Gaksch, M; Grübler, MR; Kraigher-Krainer, E; Pieske, B; Meinitzer, A; Rus-Machan, J; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A
9B.05: ASSOCIATION OF PLASMA PARATHYROID HORMONE WITH NIGHTTIME BLOOD PRESSURE IN PRIMARY HYPERPARATHYROIDISM-THE "EPLERENONE IN PRIMARY HYPERPARATHYROIDISM" TRIAL.
J Hypertens. . 2015; 33 Suppl 1(10):e121-e121.
Doi: 10.1097/01.hjh.0000467677.24307.ad
[Oral Communication]
Web of Science
PubMed
FullText
FullText_MUG
** Belyavskiy, E; Kraigher-Krainer, E; Url-Michitsch, M; Kapl, M; Schmidt, A; Pieske, B;
Diastolic stress test and new imaging modalities in detection of impaired systolic and diastolic function in patients with hypertensive heart disease and heart failure with preserved ejection fraction.
EUR J HEART FAIL. . 2014; 16: 92-92.
[Poster]
Web of Science
** Belyavskiy, E; Kraigher-Krainer, E; Url-Michitsch, M; Steiner, G; Schmidt, A; Pieske, B;
Novel echocardiographic parameters during exercise improve detection of impaired systolic and diastolic function in stage B heart failure with preserved ejection fraction.
EUR HEART J. . 2013; 34: 453-453.-Congress of the European-Society-of-Cardiology (ESC); AUG 31-SEP 04, 2013; Amsterdam, NETHERLANDS.
[Poster]
Web of Science